Skip to main content
SpringerLink
Log in

Recent R&D Highlights

  • News & Views
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The results have been published in JAMA 2005; 293 (18):2245–2256.

References

  1. Wake Forest University Baptist Medical Center. Molecular Approaches to Brain Tumor Treatment. Media release: 7 May 2005

    Google Scholar 

  2. Sirna Therapeutics. Sirna Therapeutics announces results from interim analysis of phase I single dose trial with Sirna-027 in patients with age-related macular degeneration. Media release: 4 May 2005

  3. New York University Medical Center. Active vaccine prevents mice from developing prion disease. Media release: 12 May 2005

    Google Scholar 

  4. Synarc. Synarc introduces a novel biomarker of cartilage degradation for arthritis clinical trials. Media release: 3 May 2005

  5. deCODE genetics. deCODE paper in JAMA described efficacy of DG031 in controlling key indicators of risk for heart attack. Media release: 10 May 2005

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Recent R&D Highlights. Pharmaceutical & Diagnostic Innovation 3, 14–15 (2005). https://doi.org/10.1007/BF03256964

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256964

Search

Navigation